{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:49:39Z","timestamp":1793083779322,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T00:00:00Z","timestamp":1699228800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014440","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011596","name":"Generalitat Valenciana Conselleria d' Educaci\u00f3, Investigaci\u00f3, Cultura i Esport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011596","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012513","name":"CIBER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012513","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.phrs.2023.106985","type":"journal-article","created":{"date-parts":[[2023,11,9]],"date-time":"2023-11-09T03:45:18Z","timestamp":1699501518000},"page":"106985","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Targeting IL-11 system as a treatment of pulmonary arterial hypertension"],"prefix":"10.1016","volume":"197","author":[{"given":"Javier","family":"Milara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In\u00e9s","family":"Roger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Montero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Artigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Escriv\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Perez-Vizcaino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Cortijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.phrs.2023.106985_bib1","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur. Respir. J."},{"issue":"12","key":"10.1016\/j.phrs.2023.106985_bib2","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.1172\/JCI60658","article-title":"Molecular pathogenesis of pulmonary arterial hypertension","volume":"122","author":"Rabinovitch","year":"2012","journal-title":"J. Clin. Investig."},{"issue":"5","key":"10.1016\/j.phrs.2023.106985_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17050761","article-title":"Molecular mechanisms of pulmonary vascular remodeling in pulmonary arterial hypertension","volume":"17","author":"Leopold","year":"2016","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.phrs.2023.106985_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.celrep.2014.01.042","article-title":"Recapitulation of developing artery muscularization in pulmonary hypertension","volume":"6","author":"Sheikh","year":"2014","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.phrs.2023.106985_bib5","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cytogfr.2015.07.011","article-title":"\"Family reunion\"--A structured view on the composition of the receptor complexes of interleukin-6-type and interleukin-12-type cytokines","volume":"26","author":"Rose-John","year":"2015","journal-title":"Cytokine Growth Factor Rev."},{"issue":"1","key":"10.1016\/j.phrs.2023.106985_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/2045893217735820","article-title":"Clinical trial protocol for TRANSFORM-UK: a therapeutic open-label study of tocilizumab in the treatment of pulmonary arterial hypertension","volume":"8","author":"Hernandez-Sanchez","year":"2018","journal-title":"Pulm. Circ."},{"issue":"1","key":"10.1016\/j.phrs.2023.106985_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74944-7","article-title":"Interleukin-11 is important for vascular smooth muscle phenotypic switching and aortic inflammation, fibrosis and remodeling in mouse models","volume":"10","author":"Lim","year":"2020","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2023.106985_bib8","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-022-02241-0","article-title":"IL-11 system participates in pulmonary artery remodeling and hypertension in pulmonary fibrosis","volume":"23","author":"Milara","year":"2022","journal-title":"Respir. Res"},{"issue":"1","key":"10.1016\/j.phrs.2023.106985_bib9","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","volume":"37","author":"Galie","year":"2016","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.phrs.2023.106985_bib10","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1136\/thoraxjnl-2013-203408","article-title":"Role of tetrahydrobiopterin in pulmonary vascular remodelling associated with pulmonary fibrosis","volume":"68","author":"Almudever","year":"2013","journal-title":"Thorax"},{"issue":"6","key":"10.1016\/j.phrs.2023.106985_bib11","doi-asserted-by":"crossref","DOI":"10.14814\/phy2.13159","article-title":"Vascular narrowing in pulmonary arterial hypertension is heterogeneous: rethinking resistance","volume":"5","author":"Rol","year":"2017","journal-title":"Physiol. Rep."},{"issue":"10","key":"10.1016\/j.phrs.2023.106985_bib12","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1164\/rccm.201512-2380OC","article-title":"Role for Runt-related Transcription Factor 2 in Proliferative and Calcified Vascular Lesions in Pulmonary Arterial Hypertension","volume":"194","author":"Ruffenach","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"2","key":"10.1016\/j.phrs.2023.106985_bib13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jaci.2014.07.011","article-title":"Mucin 1 downregulation associates with corticosteroid resistance in chronic rhinosinusitis with nasal polyps","volume":"135","author":"Milara","year":"2015","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.phrs.2023.106985_bib14","doi-asserted-by":"crossref","unstructured":"J. Milara, G. Juan, J.L. Ortiz, R. Guijarro, M. Losada, A. Serrano, E.J. Morcillo, J. Cortijo, Cigarette smoke-induced pulmonary endothelial dysfunction is partially suppressed by sildenafil, Eur J Pharm Sci 39(5) 363\u2013372.","DOI":"10.1016\/j.ejps.2010.01.005"},{"key":"10.1016\/j.phrs.2023.106985_bib15","unstructured":"J. Milara, J. Ortiz, G. Juan, R. Guijarro, P. Almudever, M. Martorell, E. Morcillo, J. Cortijo, Cigarette smoke exposure up-regulates endothelin receptor B in human pulmonary artery endothelial cells: molecular and functional consequences, Br J Pharmacol."},{"key":"10.1016\/j.phrs.2023.106985_bib16","doi-asserted-by":"crossref","unstructured":"J.L. Ortiz, J. Milara, G. Juan, J.L. Montesinos, M. Mata, M. Ramon, E. Morcillo, J. Cortijo, Direct effect of cigarette smoke on human pulmonary artery tension, Pulm Pharmacol Ther 23(3) 222\u2013228.","DOI":"10.1016\/j.pupt.2009.11.001"},{"issue":"511","key":"10.1016\/j.phrs.2023.106985_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw1237","article-title":"Interleukin-11 is a therapeutic target in idiopathic pulmonary fibrosis","volume":"11","author":"Ng","year":"2019","journal-title":"Sci. Transl. Med"},{"issue":"3","key":"10.1016\/j.phrs.2023.106985_bib18","doi-asserted-by":"crossref","first-page":"813","DOI":"10.4049\/jimmunol.139.3.813","article-title":"Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1","volume":"139","author":"Nordan","year":"1987","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106985_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s13075-016-1122-y","article-title":"Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study","volume":"18","author":"Corallo","year":"2016","journal-title":"Arthritis Res Ther."},{"issue":"4","key":"10.1016\/j.phrs.2023.106985_bib20","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1183\/09031936.00021411","article-title":"Bosentan inhibits cigarette smoke-induced endothelin receptor expression in pulmonary arteries","volume":"39","author":"Milara","year":"2012","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.phrs.2023.106985_bib21","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1165\/rcmb.2018-0368OC","article-title":"Systems Analysis of the Human Pulmonary Arterial Hypertension Lung Transcriptome","volume":"60","author":"Stearman","year":"2019","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"6","key":"10.1016\/j.phrs.2023.106985_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PLoS Biol."},{"issue":"2","key":"10.1016\/j.phrs.2023.106985_bib23","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41385-020-00343-w","article-title":"MUC4 is overexpressed in idiopathic pulmonary fibrosis and collaborates with transforming growth factor beta inducing fibrotic responses","volume":"14","author":"Milara","year":"2021","journal-title":"Mucosal Immunol."},{"issue":"3","key":"10.1016\/j.phrs.2023.106985_bib24","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/j.1476-5381.2008.00041.x","article-title":"Roflumilast, a phosphodiesterase 4 inhibitor, alleviates bleomycin-induced lung injury","volume":"156","author":"Cortijo","year":"2009","journal-title":"Br. J. Pharm."},{"issue":"1","key":"10.1016\/j.phrs.2023.106985_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1164\/ajrccm\/138.1.136","article-title":"The use of the internal perimeter to compare airway size and to calculate smooth muscle shortening","volume":"138","author":"James","year":"1988","journal-title":"Am. Rev. Respir. Dis."},{"issue":"6","key":"10.1016\/j.phrs.2023.106985_bib26","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1136\/thoraxjnl-2017-210728","article-title":"JAK2 mediates lung fibrosis, pulmonary vascular remodelling and hypertension in idiopathic pulmonary fibrosis: an experimental study","volume":"73","author":"Milara","year":"2018","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.phrs.2023.106985_bib27","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1183\/09031936.00183214","article-title":"Preclinical validation and imaging of Wnt-induced repair in human 3D lung tissue cultures","volume":"46","author":"Uhl","year":"2015","journal-title":"Eur. Respir. J."},{"issue":"6","key":"10.1016\/j.phrs.2023.106985_bib28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.phrs.2008.05.001","article-title":"Hawthorn extract inhibits human isolated neutrophil functions","volume":"57","author":"Dalli","year":"2008","journal-title":"Pharm. Res"},{"issue":"6","key":"10.1016\/j.phrs.2023.106985_bib29","doi-asserted-by":"crossref","first-page":"3440","DOI":"10.1016\/S0021-9258(19)83641-4","article-title":"A new generation of Ca2+ indicators with greatly improved fluorescence properties","volume":"260","author":"Grynkiewicz","year":"1985","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.phrs.2023.106985_bib30","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1164\/rccm.201909-1884OC","article-title":"TWIST1 Drives Smooth Muscle Cell Proliferation in Pulmonary Hypertension via Loss of GATA-6 and BMPR2","volume":"202","author":"Fan","year":"2020","journal-title":"Am. J. Respir. Crit. care Med."},{"issue":"7683","key":"10.1016\/j.phrs.2023.106985_bib31","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/nature24676","article-title":"IL-11 is a crucial determinant of cardiovascular fibrosis","volume":"552","author":"Schafer","year":"2017","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.phrs.2023.106985_bib32","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2217\/imt.15.17","article-title":"IL-11 signaling as a therapeutic target for cancer","volume":"7","author":"Putoczki","year":"2015","journal-title":"Immunotherapy"},{"issue":"6","key":"10.1016\/j.phrs.2023.106985_bib33","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nrd.2018.45","article-title":"Interleukin-6: designing specific therapeutics for a complex cytokine","volume":"17","author":"Garbers","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.phrs.2023.106985_bib34","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.celrep.2016.01.053","article-title":"Proteolytic Cleavage Governs Interleukin-11 Trans-signaling","volume":"14","author":"Lokau","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.phrs.2023.106985_bib35","doi-asserted-by":"crossref","first-page":"14079","DOI":"10.1038\/ncomms14079","article-title":"TNFalpha drives pulmonary arterial hypertension by suppressing the BMP type-II receptor and altering NOTCH signalling","volume":"8","author":"Hurst","year":"2017","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.phrs.2023.106985_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22042144","article-title":"mTOR Signaling in Pulmonary Vascular Disease: Pathogenic Role and Therapeutic Target","volume":"22","author":"Babicheva","year":"2021","journal-title":"Int J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2023.106985_bib37","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02341-2020","article-title":"Targeting transforming growth factor-beta receptors in pulmonary hypertension","volume":"57","author":"Guignabert","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"5","key":"10.1016\/j.phrs.2023.106985_bib38","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1164\/rccm.201812-2290OC","article-title":"PFKFB3 in smooth muscle promotes vascular remodeling in pulmonary arterial hypertension","volume":"200","author":"Kovacs","year":"2019","journal-title":"Am. J. Respir. Crit. Care Med"},{"issue":"9","key":"10.1016\/j.phrs.2023.106985_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22094980","article-title":"The role of JAK\/STAT molecular pathway in vascular remodeling associated with pulmonary hypertension","volume":"22","author":"Roger","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2023.106985_bib40","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03957-2020","article-title":"Endothelial cells in the pathogenesis of pulmonary arterial hypertension","volume":"58","author":"Evans","year":"2021","journal-title":"Eur. Respir. J."},{"issue":"1","key":"10.1016\/j.phrs.2023.106985_bib41","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01887-2018","article-title":"Pathology and pathobiology of pulmonary hypertension: state of the art and research perspectives","volume":"53","author":"Humbert","year":"2019","journal-title":"Eur. Respir. J."},{"issue":"11","key":"10.1016\/j.phrs.2023.106985_bib42","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/CIRCULATIONAHA.114.008750","article-title":"Endothelial-to-mesenchymal transition in pulmonary hypertension","volume":"131","author":"Ranchoux","year":"2015","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.phrs.2023.106985_bib43","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/cvr\/cvy004","article-title":"Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension","volume":"114","author":"Stenmark","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.phrs.2023.106985_bib44","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1164\/rccm.202110-2274OC","article-title":"Macrophage-NLRP3 activation promotes right ventricle failure in pulmonary arterial hypertension","volume":"206","author":"Al-Qazazi","year":"2022","journal-title":"Am. J. Respir. Crit. Care Med"},{"key":"10.1016\/j.phrs.2023.106985_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.106750","article-title":"Inhibiting IL-6 in medicine: a new twist to sustain inhibition of his cytokine tin the therapy of pulmonary arterial hypertension","volume":"192","author":"Gugliandolo","year":"2023","journal-title":"Pharm. Res"},{"issue":"4","key":"10.1016\/j.phrs.2023.106985_bib46","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.tiv.2013.12.016","article-title":"Assessment of immunotoxicity induced by chemicals in human precision-cut lung slices (PCLS)","volume":"28","author":"Lauenstein","year":"2014","journal-title":"Toxicol. Vitr.: Int. J. Publ. Assoc. BIBRA"},{"issue":"2","key":"10.1016\/j.phrs.2023.106985_bib47","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1165\/ajrcmb.24.2.3545","article-title":"Cytokine-induced bronchoconstriction in precision-cut lung slices is dependent upon cyclooxygenase-2 and thromboxane receptor activation","volume":"24","author":"Martin","year":"2001","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"issue":"1","key":"10.1016\/j.phrs.2023.106985_bib48","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-018-0876-y","article-title":"Differential effects of Nintedanib and Pirfenidone on lung alveolar epithelial cell function in ex vivo murine and human lung tissue cultures of pulmonary fibrosis","volume":"19","author":"Lehmann","year":"2018","journal-title":"Respir. Res."},{"issue":"2","key":"10.1016\/j.phrs.2023.106985_bib49","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.lfs.2013.12.215","article-title":"Inhibition of vascular endothelial growth factor receptor under hypoxia causes severe, human-like pulmonary arterial hypertension in mice: potential roles of interleukin-6 and endothelin","volume":"118","author":"Van Hung","year":"2014","journal-title":"Life Sci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823003419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661823003419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T22:53:37Z","timestamp":1760914417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661823003419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":49,"alternative-id":["S1043661823003419"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106985","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting IL-11 system as a treatment of pulmonary arterial hypertension","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2023.106985","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106985"}}